MEDP position history
The shares of Medpace (MEDP) that Vulcan Value Partners, LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 308,504 shares, $58M, 0.31% of portfolio
- 2021 Q4: 465,240 shares, $101M, 0.26% of portfolio, Add +50.8%
- 2022 Q1: 561,643 shares, $92M, 0.56% of portfolio, Add +20.7%
- 2022 Q2: 415,808 shares, $62M, 0.61% of portfolio, Reduce −26.0%
- 2022 Q3: 401,203 shares, $63M, 0.74% of portfolio, Reduce −3.5%
- 2022 Q4: 153,342 shares, $33M, 0.44% of portfolio, Reduce −61.8%
- 2023 Q1: 220,571 shares, $41M, 0.52% of portfolio, Add +43.8%
- 2023 Q2: 192,008 shares, $46M, 0.58% of portfolio, Reduce −12.9%
- 2023 Q3: 140,119 shares, $34M, 0.52% of portfolio, Reduce −27.0%
- 2023 Q4: 102,260 shares, $31M, 0.46% of portfolio, Reduce −27.0%
- 2024 Q1: 76,516 shares, $31M, 0.45% of portfolio, Reduce −25.2%
- 2024 Q2: 38,600 shares, $16M, 0.24% of portfolio, Reduce −49.6%
- 2024 Q3: 46,101 shares, $15M, 0.26% of portfolio, Add +19.4%
- 2024 Q4: 101,338 shares, $34M, 0.56% of portfolio, Add +119.8%
- 2025 Q1: 325,916 shares, $99M, 1.9% of portfolio, Add +221.6%
- 2025 Q2: 287,459 shares, $97M, 1.7% of portfolio, Reduce −11.8%
- 2025 Q3: 200,172 shares, $103M, 1.9% of portfolio, Reduce −30.4%
- 2025 Q4: 47,306 shares, $27M, 0.49% of portfolio, Reduce −76.4%
- 2026 Q1: 203,068 shares, $98M, 2.6% of portfolio, Add +329.3%
- 2026 Q2: 141,743 shares, $75M, 2.3% of portfolio, Reduce −30.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|